Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Silencing Mediator for Retinoid and Thyroid hormone receptor (SMRT) is a nuclear corepressor protein that plays a central role in the regulation of gene expression by nuclear receptors, including those for retinoids and thyroid hormones. SMRT functions primarily by repressing transcription in the absence of ligand binding to these receptors. It modulates adipocyte function by influencing adipogenesis, insulin sensitivity, leptin expression, lipolysis regulation via glucocorticoid signaling, and overall fat mass expansion. Altered expression levels have been observed in breast cancer tissues, and dysfunctional SMRT may contribute to obesity-related pathologies or type 2 diabetes risk profiles.
Transcriptional repression via recruitment of histone deacetylases and chromatin remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Silencing Mediator for Retinoid and Thyroid Hormone Receptor (SMRT).